Bosun Asset Management’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$659K Sell
2,984
-1,016
-25% -$281K 0.34% 39
2026
Q1
$1.18M Hold
4,000
0.63% 22
2025
Q4
$1.09M Buy
4,000
+1,000
+33% +$272K 0.53% 24
2025
Q3
$811K Buy
3,000
+110
+4% +$29.9K 0.42% 26
2025
Q2
$797K Hold
2,890
0.24% 96
2025
Q1
$767K Hold
2,890
0.33% 76
2024
Q4
$671K Hold
2,890
0.29% 100
2024
Q3
$638K Sell
2,890
-1
-0% -$207 0.3% 96
2024
Q2
$568K Hold
2,891
0.34% 77
2024
Q1
$622K Hold
2,891
0.35% 98
2023
Q4
$609K Hold
2,891
0.61% 47
2023
Q3
$579K Hold
2,891
0.63% 45
2023
Q2
$536K Sell
2,891
-3,200
-53% -$591K 0.53% 47
2023
Q1
$1.17M Buy
6,091
+2,200
+57% +$398K 1.33% 12
2022
Q4
$654K Hold
3,891
0.93% 21
2022
Q3
$689K Buy
3,891
+800
+26% +$158K 1.07% 16
2022
Q2
$633K Hold
3,091
0.87% 24
2022
Q1
$735K Sell
3,091
-7
-0.2% -$1.64K 0.77% 22
2021
Q4
$708K Buy
+3,098
New +$682K 0.64% 23

Other funds holding CME

Bosun Asset Management's CME Position: Q2 2026 in Review

Bosun Asset Management reduced its CME Group (CME) stake by 25% in Q2 2026, selling an estimated $281K and leaving 2,984 shares worth $659K. The position accounts for 0.34% of the portfolio, ranked #39.

Bosun Asset Management first reported a position in CME in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.18M in Q1 2026. 1,703 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Bosun Asset Management held 2,984 shares of CME Group worth $659K as of Q2 2026.
  • Bosun Asset Management sold 1,016 CME Group shares in Q2 2026, an estimated $281K.
  • CME Group made up 0.34% of Bosun Asset Management's portfolio in Q2 2026, its #39 holding.
  • Bosun Asset Management first reported a position in CME Group in Q4 2021 and has held it in 19 quarters since.
  • Bosun Asset Management's CME Group position peaked at $1.18M in Q1 2026.
  • 1,703 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Bosun Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.